Global Transplantation Market is valued at USD 11.99 Billion in 2021 and expected to reach USD 24.81 Billion by 2028 with a CAGR of 10.8% over the forecast period.
Global Transplantation Market: Global Size, Trends, Competitive, and Historical & Forecast Analysis, 2022-2029: The industry is predicted to register remarkable growth owing to the rising frequencies of acute illnesses, increasing instances of organ malfunctions worldwide, surge in the number of tissue banks, as well as a higher transplantation surviving success percentage.
Transplantation is among contemporary medicine's most sophisticated and significant accomplishments. Transplantation is the medical removal of an organ, tissues, or cells through one patient and placement in other individuals whose organ has collapsed. The former is known as a supplier, while the other is known as a receiver. Transplantation is often regarded as the final treatment option in situations of organ dysfunction or damage caused by any illness or accident. Sepsis, a severe reaction to an illness that generates inflammation substances to be pumped into the circulation, may induce organ failure.
The surge in organ dysfunction has boosted the number of people on the registration list for transplants. Heart, liver, kidneys, pancreas, thymus, intestine, and uterine transplants have all proven effective. Bones, tendons, corneas, skin, heart chambers, nerves, and veins are examples of tissues. The kidneys are among the most often donated organs in the world, followed by the liver and finally the heart. Corneal as well as musculoskeletal grafts are among the most frequently transplanted materials, outnumbering organ transplantation by a factor of ten.
The COVID-19 outbreak has had a minor effect on healthcare institutions and the economy. The decrease in transplantation, as well as organ donation operations, is mostly due to reasons including involved surgeons, a lack of facilities, a lockdown, and travel limitations.
Patients who tested positive for COVID-19 were barred from giving organs due to the risk of infection. Nevertheless, the growing demand for organ transplantation as a result of increased organ failure rates globally is likely to push the transplantation industry development throughout the projected timeline.
The prominent players present in this market are -
3D organ/tissue manufacturing is a novel technique for producing live human cells or organs for regenerative therapy and tissue architecture. In the United States, 105,892 people are currently on the nationwide organ waiting list for transplants as of March 2022, based on the Health Resources & Services Administration.
Additionally, according to CNN Health, live donors contribute just around 6,000 organs every year on average, indicating a huge supply-demand disparity. As a result, a novel 3D printing technique aimed at producing an organ/tissue that is identical to the one within the body is predicted to meet the organ's need and revolutionize the marketplace.
To address immunologic barriers, emerging innovations including decellularization as well as recellularization, three-dimensional (3D) bioprinting, and interspecies organogenesis are being used. Leading manufacturers are working on introducing new tissue products to the market. For example, AlloSource introduced the AlloMend Ultra-Thick Acellular Dermal Matrix (ADM) in August 2021 to develop breakthrough cellular and tissue solutions to assist surgeons in healing their patients. Consequently, adding such distinctive instruments will drastically improve the market growth.
There is a rising demand for these treatments to properly manage the critically sick patient community; nevertheless, one of the major impediments to industry expansion is the lengthy wait periods for transplantation operations, particularly in developing nations. According to Health Systems Bureau (HSB) (2021) figures, there are 90,483 kidney sufferers and 11,891 liver patients on that standby list in the United States. There were 206 applicants in the United States awaiting an intestinal transplant as of November 1, 2022.
An organ transplant may be made by both a dead and a live donor as long as oxygen and blood are circulating through the organs unless they are recovered. There are presently approximately 105,700 persons in the United States awaiting organ transplantation. Nevertheless, fewer organ donations will ultimately lengthen the wait for these treatments.
Geographically, North America is likely to maintain its dominant position in the transplantation industry throughout the projected timeframe. Countries with well-funded organizations, facilities, and official engagement in raising funds and raising awareness to facilitate organ transplantation for sufferers include the United States and Canada.
For example, based on the National Institute of Health, the financing for transplantation studies in June 2021 was $ 650 million, $ 733 million, and $ 721 million in 2018, 2019, and 2020, correspondingly. Increasing financing for transplantation studies would consequently contribute to increasing transplant usage, propelling market expansion in this area.
The Asia Pacific market is expected to grow at the fastest rate during the estimation timeframe, owing to increased investigation on regenerative medicine for the development of in-vitro tissues and organs, in addition to constructing healthcare facilities in Asian nations such as Thailand, India, the Philippines, and Indonesia.
The soaring incidence of numerous chronic illnesses, as well as the rising number of road traffic accidents, are affecting perpetual organ failure, necessitating the substitute of damaged organ systems with healthful organs in exchange to preserve the patient's life, which are significant variables driving revenue expansion in this area.
Penn Medicine's Penn Transplant Center Launched a Dedicated Center For Living Donation, Expanding Penn's Superior Care For Existing Donors
On December 19th, 2022; Penn Medicine's Penn Transplant Center has inaugurated a dedicated Center for Living Donation, expanding Penn's superior care for existing donors and working to maximize the proportion of lives saved via liver and kidney transplantation. The professionals at the facility will seek to offer high-quality care for transplantation patients and recipients, while also expanding possibilities for people in need of transplants to obtain the organs they require—and a shot at a bright future. Via community events, instructional sessions, collaborations with local groups, and marketing initiatives, the center will also strive to educate the larger Philadelphia population about the security and effect of living-donor transplantation.
Medanta Hospital In Bangalore Completed The Country's First Three-Way Transplantation Swap In Which Three Patients Got Life-Saving Liver Donations At The Same Time
On December 23th, 2022; A team of specialists at Medanta Hospital in Bangalore completed the country's first three-way transplantation swap, or matched interchange, in which three patients got life-saving liver donations at the same time. For more than 12 hours, a team of 55 physicians and nurses collaborated in six surgical rooms to achieve this mammoth operation. The matched exchange was organized in a manner that all 3 patients got an appropriate amount of a blood group-suitable liver.
Yashoda Hospitals and CMRI joined Forces To Provide Heart And Lung Transplantation Services
On May 22th, 2022; Yashoda Hospitals in Hyderabad as well as CMRI in Kolkata have joined forces to provide Heart and Lung Transplantation Services, ECMO, including Thoracic Surgery. The two organizations signed a memorandum of understanding (MOU) on the subject.
|2016 - 2021
|2022 - 2029
|Market Size in 2021:
|USD 11.99 Billion
|Base year considered
|Forecast Period CAGR %:
|Market Size Expected in 2028:
|USD 24.81 Billion
|Tables, Charts & Figures:
|Illumina, Inc., Abbott, F. Hoffmann-La Roche Ltd, Veloxis Pharmaceuticals, Inc., CareDx, Inc., Dickinson, and Company (BD), Becton, Bio-Rad Laboratories, Inc., bioMérieux SA, Hologic, Inc, and QIAGEN
|By Product, By End-User, By Application
|North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us firstname.lastname@example.orgJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®